• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠中模拟甲状腺癌。

Modeling thyroid cancer in the mouse.

作者信息

Zhu X-G, Cheng S-Y

机构信息

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, USA.

出版信息

Horm Metab Res. 2009 Jun;41(6):488-99. doi: 10.1055/s-0029-1215572. Epub 2009 Apr 8.

DOI:10.1055/s-0029-1215572
PMID:19358084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3464089/
Abstract

Thyroid carcinomas, the most common endocrine tumors in humans, have an increasing incidence in the U.S. and worldwide. There are four major types of thyroid cancers: papillary, follicular, anaplastic, and medullary carcinomas. In recent years, significant progress has been made in the identification of genetic alterations in thyroid carcinomas, particularly, papillary and medullary thyroid cancers. Mouse models of thyroid cancer are valuable tools in elucidating molecular genetic changes underlying thyroid carcinogenesis and in identifying potential molecular targets for therapeutic intervention. Representative mouse models of papillary, follicular, and medullary carcinomas are reviewed here with particular emphasis on those for follicular thyroid carcinomas. Challenges for further development in the modeling of thyroid cancer will also be discussed.

摘要

甲状腺癌是人类最常见的内分泌肿瘤,在美国和全球范围内其发病率都在上升。甲状腺癌主要有四种类型:乳头状癌、滤泡状癌、未分化癌和髓样癌。近年来,在甲状腺癌,尤其是乳头状和髓样甲状腺癌的基因改变识别方面取得了重大进展。甲状腺癌小鼠模型是阐明甲状腺癌发生的分子遗传变化以及识别治疗干预潜在分子靶点的宝贵工具。本文综述了乳头状癌、滤泡状癌和髓样癌的代表性小鼠模型,特别强调了滤泡状甲状腺癌的模型。还将讨论甲状腺癌建模进一步发展面临的挑战。

相似文献

1
Modeling thyroid cancer in the mouse.在小鼠中模拟甲状腺癌。
Horm Metab Res. 2009 Jun;41(6):488-99. doi: 10.1055/s-0029-1215572. Epub 2009 Apr 8.
2
Genetic alterations in thyroid cancer: the role of mouse models.甲状腺癌中的基因改变:小鼠模型的作用
Vet Pathol. 2007 Jan;44(1):1-14. doi: 10.1354/vp.44-1-1.
3
SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.SIN1是mTOR-Rictor复合物的关键组成部分,在髓样和侵袭性乳头状甲状腺癌中过表达并与AKT激活相关。
Surgery. 2014 Dec;156(6):1542-8; discussion 1548-9. doi: 10.1016/j.surg.2014.08.095. Epub 2014 Nov 11.
4
Poorly Differentiated and Undifferentiated Thyroid Carcinomas.低分化及未分化甲状腺癌
Turk Patoloji Derg. 2015;31 Suppl 1:48-59. doi: 10.5146/tjpath.2015.01314.
5
The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.微小 RNA 在不同类型甲状腺癌中的作用:全面分析以寻找新的 miRNA 补充治疗方法。
J Endocrinol Invest. 2018 Mar;41(3):269-283. doi: 10.1007/s40618-017-0735-6. Epub 2017 Jul 31.
6
[Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].[甲状腺良恶性上皮性肿瘤的细胞角蛋白表达。应用8种不同单克隆细胞角蛋白抗体对154例肿瘤进行的免疫组织学研究]
Pathologe. 1996 Nov;17(6):425-32. doi: 10.1007/s002920050181.
7
p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.p53 限制了 BRAF 突变型甲状腺乳头状癌小鼠模型向间变性甲状腺癌的进展。
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):E1600-9. doi: 10.1073/pnas.1404357111. Epub 2014 Apr 7.
8
Targeted therapy: a new hope for thyroid carcinomas.靶向治疗:甲状腺癌的新希望。
Crit Rev Oncol Hematol. 2015 Apr;94(1):55-63. doi: 10.1016/j.critrevonc.2014.10.012. Epub 2014 Nov 1.
9
Familial follicular cell tumors: classification and morphological characteristics.家族性滤泡细胞肿瘤:分类和形态学特征。
Endocr Pathol. 2010 Dec;21(4):219-26. doi: 10.1007/s12022-010-9135-6.
10
[Medullary thyroid carcinoma and other rare types of thyroid carcinoma].[甲状腺髓样癌及其他罕见类型的甲状腺癌]
Nihon Rinsho. 2007 Nov;65(11):2087-91.

引用本文的文献

1
Development of animal models to study aggressive thyroid cancers.用于研究侵袭性甲状腺癌的动物模型的开发。
Eur Thyroid J. 2025 Feb 10;14(1). doi: 10.1530/ETJ-24-0361. Print 2025 Feb 1.
2
Advances in cellular therapy for the treatment of thyroid cancer.甲状腺癌治疗的细胞疗法进展。
J Oncol. 2010;2010:179491. doi: 10.1155/2010/179491. Epub 2010 Jun 29.
3
Thyroid stem cells--danger or resource?甲状腺干细胞——危险还是资源?
Acta Otorhinolaryngol Ital. 2009 Dec;29(6):290-5.

本文引用的文献

1
The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer.PAX8/PPARγ 融合癌基因在甲状腺癌中的作用。
PPAR Res. 2008;2008:672829. doi: 10.1155/2008/672829. Epub 2008 Oct 29.
2
Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.人类甲状腺肿瘤:来自E7和RET/PTC3转基因小鼠的令人困惑的教训
Br J Cancer. 2008 Dec 2;99(11):1874-83. doi: 10.1038/sj.bjc.6604740. Epub 2008 Nov 4.
3
RAS: target for cancer therapy.RAS:癌症治疗靶点。
Cancer Invest. 2008 Nov;26(9):948-55. doi: 10.1080/07357900802087275.
4
Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.RET/PTC3和E7转基因小鼠甲状腺中的基因表达:RET/PTC3肿瘤而非E7肿瘤是人类乳头状甲状腺癌的部分和短暂模型。
Endocrinology. 2008 Oct;149(10):5107-17. doi: 10.1210/en.2008-0531. Epub 2008 Jun 26.
5
Dysregulated RET signaling in thyroid cancer.甲状腺癌中RET信号传导失调
Endocrinol Metab Clin North Am. 2008 Jun;37(2):363-74, viii. doi: 10.1016/j.ecl.2008.02.006.
6
Update on thyroid cancer.甲状腺癌最新进展
Horm Metab Res. 2008 May;40(5):323-8. doi: 10.1055/s-2008-1073155.
7
Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.甲状腺激素β受体的新型非基因组作用对β-连环蛋白的调控
Mol Cell Biol. 2008 Jul;28(14):4598-608. doi: 10.1128/MCB.02192-07. Epub 2008 May 12.
8
RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.MEN2、MEN2B、甲状腺髓样癌及其他甲状腺癌形式中的RET原癌基因。
Expert Rev Anticancer Ther. 2008 Apr;8(4):625-32. doi: 10.1586/14737140.8.4.625.
9
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
10
Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.甲状腺癌的分子遗传学:对诊断、治疗及预后的影响
Expert Rev Mol Diagn. 2008 Jan;8(1):83-95. doi: 10.1586/14737159.8.1.83.